The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practices-Reference-Cited by-同舟云学术

The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practices

Published:2021-02-28 Issue:1 Volume:15 Page:9-15
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Cheng Haihong¹,Zhou Di²,Wang Shouhua²,Ding Jun³,Ma Fei¹⁴

Affiliation:

1. Department of Oncology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

2. Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

3. Department of Biliary and Pancreatic Surgery, Shanghai Shuguang Hospital Affiliated with the Shanghai University of T.C.M., Shanghai, China.

4. Shanghai Institute for Pediatric Research, Shanghai, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/15/1/15_2020.01039/_pdf

Reference46 articles.

1. 1. Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, de Ruiz PA, Urista GA, Nervi F. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001; 51:349-364.

2. 2. Palucka AK, Coussens LM. The basis of oncoimmunology. Cell. 2016; 164:1233-1247.

3. 3. Park K, Kim KP, Park S, Chang HM. Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer. Asia Pac J Clin Oncol. 2017; 13:13-20.

4. 4. Kawamoto M, Wada Y, Koya N, Takami Y, Saitsu H, Ishizaki N, Tabata M, Onishi H, Nakamura M, Morisaki T. Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: A case report. Surg Case Rep. 2018; 4:115.

5. 5. Bhamare S, Prabhakar P, Dharmadhikari A, Dedeepiya VD, Terunuma H, Senthilkumar R, Srinivasan T, Reena HC, Preethy S, Abraham SJ. Autologous immune enhancement therapy in a case of gall bladder cancer stage IV after surgical resection and chemotherapy yielding a stable non-progressive disease. J Cancer Res Ther. 2014; 10:752-754.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: A report of five cases and a literature review;Frontiers in Immunology;2023-03-20

2. Update on immunotherapy in the management of gallbladder cancer;Immunotherapy;2023-01

3. Recurrent Gallbladder Carcinoma With pMMR/MSS Achieved a Complete Response Following Camrelizumab Combined With Apatinib: A Case Report;Frontiers in Oncology;2022-01-13